Entrada Therapeutics is engaging a consultant to provide interim, full-time support to the SEC Reporting & Technical Accounting function from approximately mid-November 2026 through early March 2027. This engagement backfills priority pre-year-end and year-end deliverables while the Associate Director, SEC Reporting temporarily takes on additional responsibilities elsewhere in the accounting organization. The Associate Director will remain involved throughout the engagement and provide oversight/guidance as necessary.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior